Clinical Trial Update: Evaluating the Efficacy of Atezolizumab in Advanced Non-small Cell Lung Cancer (NSCLC) [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating the efficacy of atezolizumab in advanced non-small cell lung cancer has completed with results posted in 2023.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Atezolizumab (atezolizumab)

Snippet

Sponsor: Liza Villaruz, MD | Conditions: Advanced Non-small Cell Lung Cancer | Phase 2 | Status: COMPLETED | Results posted: 2023-12-13